VR Adviser, LLC Q1 2020 Filing
Filed May 15, 2020
Portfolio Value
$369.2B
Holdings
16
Report Date
Q1 2020
Filing Type
13F-HR
All Holdings (16 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —CONSTELLATION PHARMACEUTICALS INC | 4,016,873 | $126.3B | 34.20% | |
| 2 | AXSMAXSOME THERAPEUTICS INC | 810,000 | $47.7B | 12.91% | |
| 3 | RLMDRELMADA THERAPEUTICS INC | 842,814 | $28.7B | 7.79% | |
| 4 | TREURTRILLIUM THERAPEUTICS INC | 6,790,000 | $27.4B | 7.43% | |
| 5 | ETNBGBP89BIO INC | 952,200 | $24.0B | 6.51% | |
| 6 | INOINOVIO PHARMACEUTICALS INC | 2,900,000 | $21.6B | 5.84% | |
| 7 | TXG10X GENOMICS INC | 300,000 | $18.7B | 5.06% | |
| 8 | —MERSANA THERAPEUTICS INC | 2,623,903 | $15.3B | 4.14% | |
| 9 | —MARINUS PHARMACEUTICALS INC | 6,502,840 | $13.2B | 3.58% | |
| 10 | VSTMVERASTEM INC | 3,720,930 | $9.8B | 2.66% | |
| 11 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 994,381 | $9.7B | 2.63% | |
| 12 | OPHTEURIVERIC BIO INC | 2,586,537 | $8.9B | 2.41% | |
| 13 | AVDLAVADEL PHARMACEUTICALS PLC | 1,057,827 | $8.4B | 2.28% | |
| 14 | —SIERRA ONCOLOGY INC | 491,017 | $4.8B | 1.31% | |
| 15 | SPROSPERO THERAPEUTICS INC | 474,015 | $3.8B | 1.04% | |
| 16 | PTGXPROTAGONIST THERAPEUTICS INC | 113,140 | $799.0M | 0.22% |